Teva Pharma Industries Ltd ADR

Yahoo Finance • 2 days ago

Teva Releases Q3 2025 Aide Memoire

TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q3 2025 Aide Memoire is available on the “Investors” page on its website. Q3 2025 Aide Memoire Teva... Full story

Yahoo Finance • 2 days ago

Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025

TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter 2025 financial results on Wednesday, November 5, 2025,... Full story

Yahoo Finance • 6 days ago

Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine) extended-release tabletsPatients reported high satisfaction (>89%) with AUSTEDO XR, wi... Full story

Yahoo Finance • 6 days ago

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-'749) and its long-term systemic safety profile was consistent with other... Full story

Yahoo Finance • 11 days ago

Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting

TEL AVIV, Israel, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced plans to present data from the completed phase 3 SOLARIS trial at the 2025 Psych Congress Annual Meeting, taki... Full story

Yahoo Finance • 11 days ago

Teva Pharmaceutical Industries Limited (TEVA)’s Emrusolmin Gains FDA Fast Track for Multiple System Atrophy

In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Teva Pharmaceutical Industries Limited is one of them. Teva Pharmaceutical Industries Limited (NYSE:TEVA), a global pharmaceutical company, continues... Full story

Yahoo Finance • 14 days ago

Insider trades: Salesforce, Broadcom among notable names this week

Companies including Salesforce (NYSE:CRM [https://seekingalpha.com/symbol/CRM]) and Broadcom (NASDAQ:AVGO [https://seekingalpha.com/symbol/AVGO]) witnessed major insider transactions this week. The following is a list of deals that took pl... Full story

Yahoo Finance • 16 days ago

J.P. Morgan Maintains a Buy on Teva Pharmaceutical (TEVA) With a $23 PT

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best growth stocks under $50 to buy now. On September 5, J.P. Morgan analyst Chris Schott maintained a Buy rating on Teva Pharmaceutical Industries Limited (NYSE:TEVA) and se... Full story

Yahoo Finance • 17 days ago

Here’s Why Sound Shore Fund Added Teva Pharmaceutical Industries Limited (TEVA) in Q2

Sound Shore Management, an investment management firm, has released its investor letter for the second quarter of 2025. A copy of the letter can be downloaded here. The fund’s Investor Class (SSHFX) and Institutional Class (SSHVX) delivere... Full story

Yahoo Finance • 19 days ago

Noteworthy ETF Inflows: IDEV, CYBR, TEVA, CCEP

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core MSCI International Developed Markets ETF (Symbol: IDEV) where we have detected an approximate $3... Full story

Yahoo Finance • 25 days ago

Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September

TEL AVIV, Israel, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in September... Full story

Yahoo Finance • 25 days ago

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

Key Points The "Dogs of the Dow" can uncover steady, high-yield stalwarts, not just temporarily cheap names. Verizon and Chevron face more long-term issues than sudden system shocks. Merck's high yield looks like a classic Dogs idea. 10 s... Full story

Yahoo Finance • 30 days ago

FDA Approves First-Ever Generic Weight-Loss Drug In A Blow To Novo Nordisk

The FDA signed off on the first-ever weight-loss generic on Thursday, a knockoff of Novo Nordisk's Saxenda from Teva Pharmaceutical. Continue Reading View Comments... Full story

Yahoo Finance • last month

Piper Sandler Reiterates a Buy Rating on Teva Pharmaceutical Industries (TEVA)

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best cheap strong buy stocks to buy now. Piper Sandler analyst David Amsellem reiterated a Buy rating on Teva Pharmaceutical Industries Limited (NYSE:TEVA) on August 18, sett... Full story

Yahoo Finance • last month

Latest Fed cut signals, pharma relief rally, Apple TV+ price hike

Yahoo Finance's John Hyland outlines three of the top stories on Wall Street as part of the Market Minute. Federal Reserve Bank of Cleveland President and CEO Beth Hammack tells Yahoo Finance at the Jackson Hole Economic Policy Symposium... Full story

Yahoo Finance • last month

Dementia Treatment Market Size to Surpass USD 33.54 Billion by 2032, Fueled by Breakthrough Therapies and Growing Patient Awareness – SNS Insider

Austin, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Dementia Treatment Market Size & Growth Outlook According to SNS Insider, the global Dementia Treatment Market was valued at USD 17.06 billion in 2023 and is projected to reach USD 33.54 billion... Full story

Yahoo Finance • last month

Israel stocks higher at close of trade; TA 35 up 0.76%

Investing.com – Israel stocks were higher after the close on Sunday, as gains in the Biomed, Banking and Financials sectors led shares higher. At the close in Tel Aviv, the TA 35 gained 0.76%. The best performers of the session on the TA... Full story

Yahoo Finance • last month

Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

New York, USA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The vitiligo treatment landscape is evolving with a shift tow... Full story

Yahoo Finance • last month

Saudi Arabia Osteoporosis Drugs Market Analysis Report 2025-2033 Featuring Amgen, Eli Lilly and Co, F. Hoffmann La Roche, GlaxoSmithKline, Merck, Novartis, Pfizer, Teva Pharmaceutical, UCB

Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia Osteoporosis Drugs Market to Reach US$ 308.84 Million by 2033 - 4.33% CAGR Driven by Biologics and Aging Population" report has been added to ResearchAndMarkets.com's offering.... Full story

Yahoo Finance • 2 months ago

Vitiligo Treatment Strategic Market Research Report 2025-2030 | Increased Psychological and Social Impact of Vitiligo Drives Demand for More Effective Therapies

Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "Vitiligo Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Vitiligo Treatment was estimated at US$1.5 Billion in 20... Full story